Jenburkt Pharmaceuticals Limited (BOM:524731)
India · Delayed Price · Currency is INR 1,050.05
-11.70 (-1.10%)
At close: Aug 17, 2026
Jenburkt Pharmaceuticals Market Cap
Jenburkt Pharmaceuticals has a market cap or net worth of 4.63 billion as of August 17, 2026. Its market cap has decreased by -10.20% in one year.
Market Cap
4.63B
Enterprise Value
4.19B
Revenue
1.69B
Ranking
n/a
PE Ratio
14.12
Stock Price
1,050.05
ChartMarket Cap Chart
Since November 21, 2001, Jenburkt Pharmaceuticals's market cap has increased from 33.01M to 4.63B, an increase of 13,938.72%. That is a compound annual growth rate of 22.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 4.63B | -3.65% |
| Dec 31, 2025 | 4.81B | -10.28% |
| Dec 31, 2024 | 5.36B | 78.59% |
| Dec 29, 2023 | 3.00B | 1.25% |
| Dec 30, 2022 | 2.96B | 21.19% |
| Dec 31, 2021 | 2.45B | 24.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anuh Pharma | 7.64B |
| Kilitch Drugs (India) | 6.24B |
| ZIM Laboratories | 5.87B |
| Amanta Healthcare | 5.37B |
| Albert David | 4.61B |
| Medico Remedies | 3.74B |
| Ambalal Sarabhai Enterprises | 3.25B |
| Trident Lifeline | 3.15B |